{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:06:47Z","timestamp":1772536007545,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.atherosclerosis.2009.03.032","type":"journal-article","created":{"date-parts":[[2009,4,6]],"date-time":"2009-04-06T08:23:44Z","timestamp":1239006224000},"page":"575-580","source":"Crossref","is-referenced-by-count":20,"title":["Association of serum osteoprotegerin with ankle-brachial index and urine albumin: Creatinine ratio in African-Americans and non-Hispanic whites"],"prefix":"10.1016","volume":"206","author":[{"given":"Zeenat","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison A.","family":"Ellington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Thomas H.","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iftikhar J.","family":"Kullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib1","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","article-title":"RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function","volume":"22","author":"Schoppet","year":"2002","journal-title":"Arteriosc Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis","volume":"192","author":"Min","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib5","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/hq1201.100229","article-title":"Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques","volume":"21","author":"Dhore","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.ATV.0000204334.48195.6a","article-title":"Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization","volume":"26","author":"Sandberg","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1042\/CS20040255","article-title":"Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein","volume":"108","author":"Rhee","year":"2005","journal-title":"Clin Sci"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib8","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jacc.2005.12.054","article-title":"The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects","volume":"47","author":"Anand","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/jc.86.2.631","article-title":"Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women","volume":"86","author":"Browner","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2265.2005.02390.x","article-title":"Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity","volume":"63","author":"Kim","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2265.2006.02522.x","article-title":"Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population","volume":"64","author":"Gannage-Yared","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib12","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.0000031524.49139.29","article-title":"Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease","volume":"106","author":"Jono","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib13","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/jc.2002-020775","article-title":"Increased osteoprotegerin serum levels in men with coronary artery disease","volume":"88","author":"Schoppet","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib14","doi-asserted-by":"crossref","unstructured":"Palazzuoli A, Ascione R, GallottaM et al. Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension. Int J Cardiol 2008, Aug 15, in press doi:10.1016\/j.ijcard.2008.05.048.","DOI":"10.1016\/j.ijcard.2008.05.048"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/CS20050058","article-title":"Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction","volume":"109","author":"Crisafulli","year":"2005","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib16","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacc.2007.09.058","article-title":"Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes","volume":"51","author":"Omland","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib18","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/archinte.163.16.1939","article-title":"The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study","volume":"163","author":"Murabito","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.ATV.19.3.538","article-title":"Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group","volume":"19","author":"Newman","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib20","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1161\/01.CIR.0000143102.38256.DE","article-title":"Improved prediction of fatal myocardial infarction using the ankle brachial index in addition to conventional risk factors: the Edinburgh Artery Study","volume":"110","author":"Lee","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(88)92657-8","article-title":"Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey","volume":"2","author":"Yudkin","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1291\/hypres.26.603","article-title":"Microalbuminuria and cardiovascular events in elderly hypertensive patients without previous cardiovascular complications","volume":"26","author":"Nakamura","year":"2003","journal-title":"Hypertens Res"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib23","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/01.ATV.19.8.1992","article-title":"Urinary albumin excretion. An independent predictor of ischemic heart disease","volume":"19","author":"Borch-Johnsen","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00041552-200003000-00008","article-title":"Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension?","volume":"9","author":"Campese","year":"2000","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib25","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1161\/01.CIR.0000121563.47232.2A","article-title":"National heart, lung, and blood institute clinical proteomics working group report","volume":"109","author":"Granger","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/hy1201.100415","article-title":"Multi-center genetic study of hypertension: the Family Blood Pressure Program (FBPP)","volume":"39","author":"Boerwinkle","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib27","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200105243442108","article-title":"Medical treatment of peripheral arterial disease and claudication","volume":"344","author":"Hiatt","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.metabol.2007.10.005","article-title":"Preclinical vascular damage in white postmenopausal women: the relevance of osteoprotegerin","volume":"57","author":"Siepi","year":"2008","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.amjcard.2006.08.064","article-title":"Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study)","volume":"99","author":"Abedin","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib31","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.2337\/diacare.28.9.2176","article-title":"Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients","volume":"28","author":"Avignon","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib32","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/01.STR.0000129790.00318.a3","article-title":"Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis","volume":"35","author":"Golledge","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib33","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jacc.2004.06.076","article-title":"Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction","volume":"44","author":"Ueland","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","article-title":"The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption","volume":"15","author":"Hofbauer","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","article-title":"Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis","volume":"14","author":"Yano","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s001980200045","article-title":"Correlates of osteoprotegerin levels in women and men","volume":"13","author":"Khosla","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib39","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1210\/jc.86.7.3162","article-title":"Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status","volume":"86","author":"Szulc","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib40","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/hq1001.097102","article-title":"Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D","volume":"21","author":"Price","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00223-001-2076-9","article-title":"Bone mineral density and the risk of peripheral arterial disease: the Rotterdam Study","volume":"70","author":"van der Klift","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002239900419","article-title":"Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women","volume":"62","author":"Barengolts","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib43","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1161\/01.ATV.20.8.1926","article-title":"Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study","volume":"20","author":"Hak","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00198-003-1550-9","article-title":"Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels","volume":"15","author":"Pennisi","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00223-003-0011-y","article-title":"Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease","volume":"74","author":"Sattler","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(01)05494-0","article-title":"Osteoprotegerin: a link between osteoporosis and arterial calcification?","volume":"358","author":"Hofbauer","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.atherosclerosis.2005.01.042","article-title":"Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease","volume":"182","author":"Ziegler","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib48","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.atherosclerosis.2008.06.031","article-title":"Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: the Framingham Offspring Study","volume":"203","author":"Murabito","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(94)91047-2","article-title":"Microalbuminuria and endothelial dysfunction in essential hypertension","volume":"344","author":"Pedrinelli","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib50","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1515\/CCLM.2001.116","article-title":"Heterogeneity of the association between plasma homocysteine and atherothrombotic disease: insights from studies of vascular structure and function","volume":"39","author":"Stehouwer","year":"2001","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/eje.0.1490039","article-title":"Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications","volume":"149","author":"Knudsen","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib52","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/ajkd.2002.31402","article-title":"Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure","volume":"39","author":"Kazama","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/eje.1.02049","article-title":"Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients","volume":"154","author":"Rasmussen","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib54","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.1074\/jbc.M010153200","article-title":"Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis","volume":"276","author":"Collin-Osdoby","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib55","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/bbrc.2000.4130","article-title":"Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells","volume":"280","author":"Hofbauer","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib56","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1091\/mbc.E04-01-0059","article-title":"The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival","volume":"15","author":"Pritzker","year":"2004","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib57","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.1074\/jbc.C000290200","article-title":"Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells","volume":"275","author":"Malyankar","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2009.03.032_bib58","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/01.ATV.0000236428.91125.e6","article-title":"Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-\/- mice","volume":"26","author":"Bennett","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009002433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009002433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T09:44:26Z","timestamp":1558259066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915009002433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0021915009002433"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.03.032","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}